McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...

Analysts in Q3 were more focused on medical-surgical challenges, a shift from Q2’s broader interest in oncology and specialty growth. McKesson delivered strong Q3 2025 results, driven by double ...

Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter ...

Valued at a market cap of $80.4 billion, McKesson Corporation (MCK) is a leading healthcare services and information ...

Connor Clark & Lunn Investment Management Ltd. grew its holdings in McKesson Co. (NYSE:MCK – Free Report) by 300.6% during ...

This growth resulted from increased third-party logistics and technology services, emphasizing McKesson's role in medication access and affordability. Conversely, its Medical-Surgical Solutions ...

McKesson has a 12-month low of $464.42 and ... Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic ...

Companies valued at $10 billion or more are generally considered “large-cap” stocks, and McKesson fits this criterion perfectly. It provides pharmaceutical distribution, medical-surgical ...